Company: SNSE
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0000950170-25-064525
Chunk: 0

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-05-06
Form: 10-Q
Item: Item 1
Chunk 0
---
SENSEI BIOTHERAPEUTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share data)

     March 31,2025

     December 31,2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     9,877

     $
     9,994

     Marketable securities

     24,454

     31,341

     Prepaid expenses

     911

     474

     Other current assets

     440

     120

     Total current assets

     35,682

     41,929

     Right of use assets - operating leases, net

     2,393

     2,804

     Right of use assets - financing leases, net

     15

     163

     Property and equipment, net

     159

     417

     Other non-current assets

     24

     48

     Total assets
      
     $
     38,273

     $
     45,361

     Liabilities and stockholders’ equity

     Current liabilities:

     Accounts payable and accrued liabilities
      
     $
     2,358

     $
     1,248

     Compensation and employee benefits liabilities

     720

     1,882

     Operating lease liabilities, current

     1,568

     1,586

     Financing lease liabilities, current

     583

     732

     Total current liabilities

     5,229

     5,448

     Operating lease liabilities, non-current

     1,022

     1,429

     Financing lease liabilities, non-current

     35

     98

     Total liabilities
      
     $
     6,286

     $
     6,975

     Commitments and contingencies (Note 6)

     Stockholders’ equity:

     Preferred stock, $0.0001 par value and 10,000,000 shares authorized as of March 31, 2025 and December 31, 2024; zero shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively

     —

     —

     Common stock, $0.0001 par value and 250,000,000 shares authorized as of March 31